KPMA to urge removal of public advertising ban on OTC drugs.

Published: 2005-04-19 06:56:00

Updated: 2005-04-19 06:56:00

The Korea Pharmaceutical Manufacturers Association (KPMA: chairman: Kim Jeong-soo) urged to the Korea Broadcasting Commission (KBC) that the public advertising ban on 12 therapeutic drug groups including drugs for liver diseases, detoxication and choleretic should be removed in accordance to the ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK